| Mr Randolph Hayes Henderson, PHYSICIAN ASSISTANT | |
|
1500 E Woodrow Wilson Drive, G V Montgomery Department Of Veterans Affairs, Jackson, MS 39216-5199 | |
| (601) 362-4471 | |
| (601) 364-1325 |
| Full Name | Mr Randolph Hayes Henderson |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 1500 E Woodrow Wilson Drive, Jackson, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366530545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA001 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Randolph Hayes Henderson, PHYSICIAN ASSISTANT 4223 Adams Station Road, Edwards, MS 39066 Ph: (601) 885-2022 | Mr Randolph Hayes Henderson, PHYSICIAN ASSISTANT 1500 E Woodrow Wilson Drive, G V Montgomery Department Of Veterans Affairs, Jackson, MS 39216-5199 Ph: (601) 362-4471 |
News Archive
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Edward Garon, Director of Thoracic Oncology, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, at the 15th World Conference on Lung Cancer in Sydney, Australia (Abstract #2416).
Currently, there are more than 350 million type 2 diabetics and according to the World Health Organization (WHO) by 2030 it will be the 7th leading cause of death worldwide.
A specialized medical research facility that will transform ground-breaking research into new medical equipment and technology is set to be established in Queensland, at the Herston Health Precinct.
Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder. In the classroom, parents and teachers say that medications like methylphenidate can reduce symptoms and improve behavior.
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
› Verified 9 days ago
David Andrew Porter, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 | |
Rowdy Chance Lee, MD Physician Assistant Medicare: Medicare Enrolled Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5153 | |
Kelsey A North, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 971 Lakeland Dr Ste 1460, Jackson, MS 39216 Phone: 513-708-4211 | |
Mary Allison Durr, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1325 E Fortification St, Jackson, MS 39202 Phone: 601-354-4488 Fax: 601-914-1835 | |
Sarah Joanna Mason, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7275 S Siwell Rd, Jackson, MS 39272 Phone: 601-373-7722 Fax: 601-373-7128 | |
Mrs. Victoria Nicole Lott, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 656, Jackson, MS 39216 Phone: 601-366-6606 | |
Heather Morris, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1190 N State St Ste 502, Jackson, MS 39202 Phone: 601-944-1781 |